teaming up

Houston esports startup scores partnerships with big gaming brands

Uconnect Esports, based in the Katy area, has secured partnerships with big gaming brands ahead of a busy 2020 season. Jamie McInall/Pexels

A esports marketplace based in the Houston area has won some big partnerships for 2020.

Uconnect Esports, which is headquartered in Katy, has announced it has formed partnerships with Twitch Student, HyperX, and Cooler Master. These new partnerships will support the company's 2020 events.

"As organization leaders of the first generation of collegiate esports, our goal at Uconnect Esports is to open an entire ecosystem for sponsorships and support," says Dylan Liu, CEO and founder of Uconnect Esports, in a news release.

Uconnect acts as a marketplace for esports players and brands by streamlining and automating the entire sponsorship process. The company first launched alpha platform in August 2019 at it's Texas Collegiate Esports Summit.

"Collegiate esports is a new space for many brands and collegiate administrators," Liu continues in the release. "We are helping both sides enter the ecosystem while prioritizing students. We want to make sure that these organizations and this ecosystem continue to be led and driven by students, with the support of administrators and brands."

Since launch, Uconnect's platform has been used at 120 collegiate esports and gaming organizations across the continent, and last spring, Uconnect connected its gamers to eight brands through 160 collegiate sponsorships. Gaming brands have taken notice to the resource the company is providing.

One of the new brand partners, Twitch Student, will use Uconnect's platform exclusively at over 100 collegiate esports and gaming events.

"Uconnect Esports continues to devote themselves to elevating collegiate gaming and esports clubs in North America," says Mark "Garvey" Candella, director of Student and Education Programs at Twitch. We are proud to continue our support for community leaders who bring students together and create opportunities for each other."

Trending News

Building Houston

 
 

BiVACOR has received fresh funding from its investors to further develop its artificial heart. Photo courtesy of BiVACOR

A Houston medical device company that is developing an artificial heart announced it has received investment funding to the tune of $18 million.

BiVACOR's investment round was led by Boston-based Cormorant Asset Management and Australia's OneVentures's Healthcare Fund III. According to the company, the funding will be deployed to continue research and development, hiring executives, and support the path to first in human trials.

“We are extremely grateful for the ongoing support from our core investors," says Thomas Vassiliades, who was named CEO of BiVACOR last year, in a news release. "This additional commitment further validates our technology and the need for improved options to treat end-stage biventricular heart failure.

“With this financing, we will be able to double the size of our organization and add key positions from the C-suite to research and development. We are well positioned to advance our preclinical activities and aim to conduct our First in Human early feasibility study planned for the end of the year,” he continues.

Billed as the first long-term treatment for patients with severe biventricular heart failure, the BiVACOR Total Artificial Heart is an implantable artificial heart that utilizes rotary blood pump technology. This technology includes magnetic levitation and is a "durable, reliable, and biocompatible heart replacement," per the company's release. It's about the size of a fist and can be used in a wide range of patients including some children and women and up to adult males.

“Under the leadership of its expert management team, the company has developed a credible strategy for growth as they march toward first in human studies,” says Jeannie Joughin, board chair and principal at One Ventures, in the release. “There is a huge gap in care for patients waiting for a heart transplant, and we are confident that BiVACOR will continue to execute its strategy to swiftly get the Total Artificial Heart into the patients who need it most.”

The company raised its $22 million series B round in early 2021, which was also led by Cormorant Asset Management and OneVentures. To date, BiVACOR has raised $60 million.

“BiVACOR continues to execute on its strategy, and there was no question that we would jump in to lead this funding,” says Bihua Chen, CEO and founder of Cormorant Asset Management. “We are impressed by BiVACOR’s world-class team and continued dedication to push the technology in the clinic. We’re excited to support their growth and vision to transform the treatment of biventricular heart failure with the world’s first fully MAGLEV total artificial heart.”

Founded in 2008, BiVACOR maintains offices in Cerritos, California, and Brisbane, Australia. The company is affiliated with Houston's Texas Heart Institute, where the world's first artificial heart was implanted. BiVACOR's headquarters is at the Texas Medical Center complex.

Trending News